Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CERS | Common Stock | Options Exercise | $69.8K | +19.1K | +10.51% | $3.66 | 200K | Jan 3, 2022 | Direct | F1 |
transaction | CERS | Common Stock | Sale | -$133K | -19.1K | -9.51% | $7.00 | 181K | Jan 3, 2022 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CERS | Option (Right to Buy) | Options Exercise | -19.1K | -11.21% | 151K | Jan 3, 2022 | Common Stock | 19.1K | $3.66 | Direct | F3, F4 |
Id | Content |
---|---|
F1 | This transaction was executed pursuant to a 10b5-1 plan. |
F2 | This transaction was executed pursuant to a 10b5-1 plan. The sales occurred in multiple trades at prices ranging from $7.000 to $7.005. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
F3 | One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter. |
F4 | Not applicable. |